Censa Pharmaceuticals

Developing drugs for Tetrahydrobiopterin deficiency and other rare CNS disorders

placeCambridge, Massachusetts, United States calendar_todayFounded 2015 groups2 employees language censapharma.com

Innovation

7 patent families — focus: Chemistry & metallurgy, Human necessities; filing pace slowing. Cited 93 times.

YearFilings
20182
20196
20204
20211
20222

Social engagement

Social engagement: 208 social following, 1 post in the last 12 months — above the industry median.

Investor mix

1 investor on record.

Investor typeCountShare
Other / undisclosed1100%
Coming soon